Method of treatment with epithelium derived T-cell factor
US5985262A · kind A · utility
10Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 1997 |
| Grant date | Nov 16, 1999 |
| Priority date | — |
| Expiry date | Feb 3, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1709
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nucleic acid sequences which encode biologically active EMF, expression vectors which direct the expression of ETF, ETE polypeptides, antibodies which specffically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.